ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

RenovaCare: Stem Cell Treatment Heals Burns In Weeks Not Months – Seeking Alpha

Seeking AlphaRenovaCare: Stem Cell Treatment Heals Burns In Weeks Not MonthsSeeking AlphaRenovaCare Inc. (OTCQB:RCAR) is a New York City-based biotechnology company developing its patented CellMist and SkinGun stem cell technologies for treating burns … Continue reading

2017-03-15 Michael Zand NEWS

Antibody Therapy Targets Cancer Stem Cells: Study | The Scientist … – The Scientist

The ScientistAntibody Therapy Targets Cancer Stem Cells: Study | The Scientist …The ScientistCT16 appears to eliminate cancer stem cells more effectively than radiation therapy in vitro and has shown promise in mice.Cancer Cells Slayed by Vitamin C |… Continue reading

2017-03-15 Michael Zand NEWS

Gene editing gets the green light, and scientists are betting these diseases will be first in line – CNBC

Continue reading

2017-03-15 Michael Zand NEWS

Immunotherapy Motolimod Fails to Improve Survival in Ovarian Cancer – Cancer Network

Immunotherapy Motolimod Fails to Improve Survival in Ovarian CancerCancer NetworkThe addition of the immune therapy motolimod to pegylated liposomal doxorubicin (PLD) failed to improve overall survival among women with recurrent epithelial ovarian carc… Continue reading

2017-03-15 Michael Zand NEWS

Immunotherapy Motolimod Fails to Improve Survival in Ovarian Cancer – Cancer Network

Immunotherapy Motolimod Fails to Improve Survival in Ovarian CancerCancer NetworkThe addition of the immune therapy motolimod to pegylated liposomal doxorubicin (PLD) failed to improve overall survival among women with recurrent epithelial ovarian carc… Continue reading

2017-03-15 Michael Zand NEWS

Cell Design Labs Announces Issuance of Broad Patent for Programmable Car-T Cells to Treat Cancer and Other … – Yahoo Finance


CNBC

Gene editing gets the green light, and scientists are betting these diseases will be first in line
CNBC
The recently discovered, hotly contested gene-editing enzyme CRISPR is poised to change the way we treat, even cure, many diseases. But treatment will come years before talk of any “cure” is reasonable, and researchers know where they’d put their money …

Continue reading

2017-03-15 Michael Zand NEWS

Cell Design Labs Announces Issuance of Broad Patent for … – EconoTimes

Cell Design Labs Announces Issuance of Broad Patent for …EconoTimesEconoTimes is a fast growing non-partisan source of news and intelligence on global economy and financial markets, providing timely, relevant, and critical …and more &raquo… Continue reading

2017-03-15 Michael Zand NEWS

Cell Design Labs Announces Issuance of Broad Patent for Programmable Car-T Cells to Treat Cancer and Other … – GlobeNewswire (press release)

Cell Design Labs Announces Issuance of Broad Patent for Programmable Car–T Cells to Treat Cancer and Other …
Yahoo Finance
“This overarching patent provides comprehensive coverage for our proprietary switch, a method of engineering a dynamic CAR–T cell for increased safety and control by incorporating activation by an ‘off-the-shelf’ FDA-approved molecule,” said Brian …

and more »

Continue reading

2017-03-15 Michael Zand NEWS
  • 1
  • …
  • 1,975
  • 1,976
  • 1,977
  • 1,978
  • 1,979
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Cell Design Labs Announces Issuance of Broad Patent for Programmable Car–T Cells to Treat Cancer and Other …
GlobeNewswire (press release)
“This overarching patent provides comprehensive coverage for our proprietary switch, a method of engineering a dynamic CAR–T cell for increased safety and control by incorporating activation by an ‘off-the-shelf’ FDA-approved molecule,” said Brian …

and more »